JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, G. J.
Right arrow Articles by Hamel, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, G. J.
Right arrow Articles by Hamel, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 265, Issue 18, 10255-10259, Jun, 1990

N-acetylcolchinol O-methyl ether and thiocolchicine, potent analogs of colchicine modified in the C ring. Evaluation of the mechanistic basis for their enhanced biological properties

GJ Kang, Z Getahun, A Muzaffar, A Brossi and E Hamel
Laboratory of Biochemical Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Two colchicine analogs with modifications only in the C ring are better inhibitors than colchicine of cell growth and tubulin polymerization. Radiolabeled thiocolchicine (with a thiomethyl instead of a methoxy group at position C-10) and N-acetylcolchinol O-methyl ether (NCME) (with a methoxy-substituted benzenoid instead of the methoxy- substituted tropone C ring) were prepared for comparison with colchicine. Scatchard analysis indicated a single binding site with KD values of 1.0-2.3 microM. Thiocolchicine was bound 2-4 times as rapidly as colchicine, but the activation energies of the reactions were nearly identical (18 kcal/mol for colchicine, 20 kcal/mol for thiocolchicine). NCME bound to tubulin in a biphasic reaction. The faster phase was 60 times as fast as colchicine binding at 37 degrees C, and a substantial reaction occurred at 0 degrees C. The rate of the faster phase of NCME binding changed relatively little as a function of temperature, so the activation energy was only 7.0 kcal/mol. Dissociation reactions were also evaluated, and at 37 degrees C the half-lives of the tubulin-drug complexes were 11 min for NCME, 24 h for thiocolchicine, and 27 h for colchicine. Relative dissociation rates as a function of temperature varied little among the drug complexes. Activation energies for the dissociation reactions were 30 kcal/mol for thiocolchicine, 27 kcal/mol for NCME, and 24 kcal/mol for colchicine. Comparison of the activation energies of association and dissociation yielded free energies for the binding reactions of -20 kcal/mol for NCME, -10 kcal/mol for thiocolchicine, and -6 kcal/mol for colchicine. The greater effectiveness of NCME and thiocolchicine as compared with colchicine in biological assays probably derives from their more rapid binding to tubulin and the lower free energies of their binding reactions.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
G. Micheletti, M. Poli, P. Borsotti, M. Martinelli, B. Imberti, G. Taraboletti, and R. Giavazzi
Vascular-targeting Activity of ZD6126, a Novel Tubulin-binding Agent
Cancer Res., April 1, 2003; 63(7): 1534 - 1537.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. D. Davis, G. J. Dougherty, D. C. Blakey, S. M. Galbraith, G. M. Tozer, A. L. Holder, M. A. Naylor, J. Nolan, M. R. L. Stratford, D. J. Chaplin, et al.
ZD6126: A Novel Vascular-targeting Agent That Causes Selective Destruction of Tumor Vasculature
Cancer Res., December 15, 2002; 62(24): 7247 - 7253.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Verdier-Pinard, Z. Wang, A. K. Mohanakrishnan, M. Cushman, and E. Hamel
A Steroid Derivative with Paclitaxel-Like Effects on Tubulin Polymerization
Mol. Pharmacol., March 1, 2000; 57(3): 568 - 575.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
P. Verdier-Pinard, J.-Y. Lai, H.-D. Yoo, J. Yu, B. Marquez, D. G. Nagle, M. Nambu, J. D. White, J. R. Falck, W. H. Gerwick, et al.
Structure-Activity Analysis of the Interaction of Curacin A, the Potent Colchicine Site Antimitotic Agent, with Tubulin and Effects of Analogs on the Growth of MCF-7 Breast Cancer Cells
Mol. Pharmacol., January 1, 1998; 53(1): 62 - 76.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
G. Chakrabarti, S. Sengupta, and B. Bhattacharyya
Thermodynamics of Colchicinoid-Tubulin Interactions
J. Biol. Chem., February 9, 1996; 271(6): 2897 - 2901.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Bai, D. G. Covell, X.-F. Pei, J. B. Ewell, N. Y. Nguyen, A. Brossi, and E. Hamel
Mapping the Binding Site of Colchicinoids on beta -Tubulin. 2-CHLOROACETYL-2-DEMETHYLTHIOCOLCHICINE COVALENTLY REACTS PREDOMINANTLY WITH CYSTEINE 239 AND SECONDARILY WITH CYSTEINE 354
J. Biol. Chem., December 15, 2000; 275(51): 40443 - 40452.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1990 by the American Society for Biochemistry and Molecular Biology.